Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Stanford researchers had been working for years on an AI-powered system to monitor elderly patients at home when the coronavirus outbreak became a global crisis. Now their work is not just nifty but needed.
A new deep learning algorithm can evaluate 134 different skin disorders, predicting malignancy and recommending key treatment options, according to new findings published in the Journal of Investigative Dermatology.
Representatives from the two companies emphasized that its effectiveness is still being validated. At this stage, it is to be used for research purposes and not as a diagnostic tool.
A tech giant is offering a free hand to healthcare experts working in various fields that could be tapping tireless AI rather than overworked humans to answer questions from the general public on COVID-19.
The images are rendered from CT scans and allow viewers to navigate the lungs in 360-degree tours, as demonstrated in a video podcast posted by George Washington University Hospital.
A disease that hits most people mildly but some very hard—and so wreaks havoc with its unpredictability among the infected—would seem a good target for AI’s predictive prowess.
